HR & Workforce entity
Every one of those 1 sits in a single category, compensation. AstraZeneca is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline.
Last mentioned: Aug 3, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, compensation. AstraZeneca is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 3 original sources per story, versus 2.4 across the same-window beat baseline. At 5, the average consequence score sits below the same-window beat average of 5.6. We currently track 1 HR & Workforce story that mention Pascal Soriot, all published on February 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 HR & Workforce stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pascal Soriot. Shared-story counts are live from our verified record — not editorial picks.
AstraZeneca CEO Pascal Soriot’s total remuneration for 2025 reached £17.7 million, driven by strong corporate performance and long-term incentives. The payout highlights the ongoing tension between UK executive pay standards and the global competition for pharmaceutical leadership talent.
Source: lbc.co.uk · borehamwoodtimes.co.uk
Pascal Soriot is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
